City

Clinical trials near Zhengzhou, China

Active studies with a listed research site in Zhengzhou, China.

15active studies

8recruiting now

12countries represented

138largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Overweight, ObesityCondition

Cagrilintide, SemaglutideTreatment

Australia, Austria121 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT07253285See eligibility →

Recruiting nowPhase 3

A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes

Obesity, OverweightCondition

Enicepatide, PlaceboTreatment

China18 locations

Hoffmann-La RocheSponsor

Updated 2026-08-13 · NCT07670416See eligibility →

Recruiting nowPhase 3

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

Chronic Management of Body WeightCondition

HRS9531 Tablet, HRS9531 Tablet PlaceboTreatment

China2 locations

Fujian Shengdi Pharmaceutical Co., Ltd.Sponsor

Updated 2026-08-13 · NCT07670884See eligibility →

Recruiting nowNot applicable

Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

ObesityCondition

BS-GLP1RA group, BS groupTreatment

China7 locations

China-Japan Friendship HospitalSponsor

Updated 2026-07-29 · NCT07732738See eligibility →

Recruiting nowNot applicable

The Impact of Lifestyle Intervention on Weight and Fertility in Obese Males

Obesity, Weight LossCondition

Low-carbohydrate diet group, Health Education GroupTreatment

China1 locations

Third Affiliated Hospital of Zhengzhou UniversitySponsor

Updated 2026-04-13 · NCT06339840See eligibility →

Recruiting nowNot applicable

China Health Big Data

Osteoporosis, ObesityCondition

Intervention not listedTreatment

China6 locations

Beijing Jishuitan HospitalSponsor

Updated 2025-08-17 · NCT03699228See eligibility →

Recruiting nowNot applicable

Mobile Applet for Weight Management in Obese Heart Failure Patients

Heart Failure, Overweight and ObesityCondition

Full usage of diet management app group and with the full usage of an intelligent weight scale, Limited usage of diet management app group and with the limited usage of an intelligent weight scaleTreatment

China26 locations

Heart Health Research CenterSponsor

Updated 2025-06-27 · NCT06455878See eligibility →

Recruiting nowNot applicable

Lactobacillus Plantarum and Hormonal Regulation in Obese Women

Obesity, WomenCondition

Probiotic, MaltodextrinTreatment

China1 locations

Wecare Probiotics Co., Ltd.Sponsor

Updated 2025-05-23 · NCT06987279See eligibility →

Opening soonPhase 3

A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

Obesity, OverweightCondition

Berobenatide, PlaceboTreatment

China33 locations

PfizerSponsor

Updated 2026-09-04 · NCT07792954See eligibility →

Opening soonPhase 1

A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention

Overweight/ObesityCondition

TQF3250 capsules, TQF3250 placeboTreatment

China10 locations

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Sponsor

Updated 2026-09-01 · NCT07798284See eligibility →

Opening soonPhase 2

Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer

Obesity, OverweightCondition

Mazdutide(Dual GLP-1R/GCGR Agonist), PlaceboTreatment

China6 locations

Tongji HospitalSponsor

Updated 2026-08-24 · NCT07781150See eligibility →

Opening soonNot applicable

Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP Trial

Obesity & Overweight, Insulin ResistanceCondition

Carbohydrate-last eating, Sequential trainingTreatment

China9 locations

Peking UniversitySponsor

Updated 2026-07-17 · NCT07712068See eligibility →

Opening soonPhase 3

A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）

Overweight or ObesityCondition

MDR-001, PlaceboTreatment

China45 locations

MindRank AI LtdSponsor

Updated 2025-12-22 · NCT07274137See eligibility →

Opening soonPhase 3

A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®

ObesityCondition

Semaglutide, SemaglutideTreatment

China14 locations

Hangzhou Jiuyuan Gene Engineering Co. Ltd.,Sponsor

Updated 2024-10-09 · NCT06633783See eligibility →

Active, not recruitingPhase 3

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Obesity, OverweightCondition

Orforglipron, PlaceboTreatment

Brazil, China138 locations

Eli Lilly and CompanySponsor

Updated 2026-08-14 · NCT05869903See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Zhengzhou, China

Current studies

Related cities